---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-22-041096"
form_type: "8-K"
ticker: "PLUR"
cik: "0001158780"
company_name: "Pluri Inc."
filed_at: "2022-07-25T23:59:59+00:00"
generated_at: "2026-06-24T09:04:39.925957+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Pluristem renamed Pluri Inc., ticker PLUR, pivots to multi-industry cell-based platform

## Summary
- Name change from Pluristem Therapeutics Inc. to Pluri Inc. effective July 26, 2022.
- Stock ticker symbol changes to 'PLUR' on Nasdaq Global Market.
- CEO Yaky Yanay outlines strategic pivot to cell-based technology for food-tech, agri-tech, and biologics.
- Commercialization strategy includes licensing and joint ventures ('Pluri focus units') with separate funding and management.
- Continues medical research but expands into non-medical cell-based solutions via partnerships.

## SEC filing metadata
- accession: 0001213900-22-041096
- form_type: 8-K
- ticker: PLUR
- cik: 0001158780
- company_name: Pluri Inc.
- filed_at: 2022-07-25T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1158780/000121390022041096/0001213900-22-041096-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1158780/000121390022041096/ea163272-8k_pluriinc.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-22-041096
- JSON: https://secwatch.observer/filing/0001213900-22-041096.json
- Plain text: https://secwatch.observer/filing/0001213900-22-041096.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.